Literature DB >> 21507492

Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.

Joost Smolders1, Mariëlle Thewissen, Ruud Theunissen, Evelyn Peelen, Stephanie Knippenberg, Paul Menheere, Jan Willem Cohen Tervaert, Raymond Hupperts, Jan Damoiseaux.   

Abstract

An impaired vitamin D (vit-D) processing by immune cells of relapsing remitting multiple sclerosis (RRMS) patients may increase their vulnerability for a poor vit-D status. We assessed with qPCR the expression of vit-D related genes in PBMC and CD4+ T-cells. Gene expression profiles of vit-D receptor (VDR), CYP27B1 and CYP24A1 did not differ between RRMS patients and healthy controls. Interestingly, more VDR expression in PBMC correlated with less circulating IFN-γ+ CD4+ T-cells. Our results suggest that vit-D processing by immune cells is not impaired in RRMS, and is potentially relevant for the composition of the peripheral CD4+ T-cell compartment.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507492     DOI: 10.1016/j.jneuroim.2011.03.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria.

Authors:  E Peelen; G Rijkers; A Meerveld-Eggink; S Meijvis; M Vogt; J W Cohen Tervaert; R Hupperts; J Damoiseaux
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-09       Impact factor: 3.267

Review 2.  Vitamin D in systemic and organ-specific autoimmune diseases.

Authors:  Nancy Agmon-Levin; Emanuel Theodor; Ramit Maoz Segal; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

3.  Expression Analysis of Vitamin D Signaling Pathway Genes in Epileptic Patients.

Authors:  Mehrdokht Mazdeh; Soudeh Ghafouri-Fard; Mahsa Hatami; Mohammad Mahdi Eftekharian; Maziar Ganji; Arezou Sayad; Shahram Arsang-Jang; Mohammad Taheri; Mir Davood Omrani
Journal:  J Mol Neurosci       Date:  2018-03-16       Impact factor: 3.444

4.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

5.  Testing in mice the hypothesis that melanin is protective in malaria infections.

Authors:  Michael Waisberg; Brandi K Vickers; Stephanie B Yager; Christina K Lin; Susan K Pierce
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

6.  Molecular mechanism underlying the impact of vitamin D on disease activity of MS.

Authors:  Kassandra L Munger; Karl Köchert; Kelly C Simon; Ludwig Kappos; Chris H Polman; Mark S Freedman; Hans P Hartung; David H Miller; Xavier Montalbán; Gilles Edan; Frederik Barkhof; Dirk Pleimes; Rupert Sandbrink; Alberto Ascherio; Christoph Pohl
Journal:  Ann Clin Transl Neurol       Date:  2014-08-22       Impact factor: 4.511

7.  VDR and CYP24A1 Expression Analysis in Iranian Relapsing-Remitting Multiple Sclerosis Patients.

Authors:  Hashem Sadeghi; Mohammad Taheri; Elham Sajadi; Abolfazl Movafagh; Shahram Arsang Jang; Arezou Sayad
Journal:  Cell J       Date:  2017-08-19       Impact factor: 2.479

Review 8.  Autoimmune disease and interconnections with vitamin D.

Authors:  Jane Fletcher; Emma L Bishop; Stephanie R Harrison; Amelia Swift; Sheldon C Cooper; Sarah K Dimeloe; Karim Raza; Martin Hewison
Journal:  Endocr Connect       Date:  2022-03-31       Impact factor: 3.221

9.  The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells.

Authors:  T Berge; I S Leikfoss; I S Brorson; S D Bos; C M Page; M W Gustavsen; A Bjølgerud; T Holmøy; E G Celius; J Damoiseaux; J Smolders; H F Harbo; A Spurkland
Journal:  Genes Immun       Date:  2016-01-14       Impact factor: 2.676

10.  Upregulation of vitamin D-related genes in schizophrenic patients.

Authors:  Fateme Asadzadeh Manjili; Seyed Mehdi Kalantar; Shahram Arsang-Jang; Soudeh Ghafouri-Fard; Mohammad Taheri; Arezou Sayad
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-09       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.